Recombinant epidermal growth factor derivative - Uni-Bio Science Group

Drug Profile

Recombinant epidermal growth factor derivative - Uni-Bio Science Group

Alternative Names: GeneSoft; rEGF derivative - Uni-Bio Science Group

Latest Information Update: 21 Nov 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Uni-Bio Science Group
  • Class Antiulcers; Growth factors
  • Mechanism of Action Epidermal growth factor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Corneal ulcer

Most Recent Events

  • 14 Nov 2016 Uni-Bio Science Group and China Resources Zizhu Pharmaceutical agree to co-promote Recombinant epidermal growth factor derivative (GeneSoft®) in China for Corneal ulcer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top